Billionaires are betting on longevity research to help us live longer
Big names like Peter Thiel and Sam Altman are part of a network of ultrawealthy investors who have poured over $5 billion into longevity research since 2000, turning what used to be niche science into a mainstream movement.
Thiel has been involved with nearly a dozen companies that collectively raised more than $700 million, signaling a real push to advance aging science—all in hopes of helping people live longer, healthier lives.
Personal stories matter here
Personal stories matter here.
Naveen Jain launched Viome Life Sciences after losing his father, investing $30 million of his own money and helping raise $230 million total from supporters like Marc Benioff.
Stephane Bancel got involved with L-Nutra after exploring fasting diets, raising $47 million for nutrition-focused programs.
And then there's Altos Labs, which has secured a massive $3 billion to work on cell rejuvenation—potentially changing how we think about aging altogether.